GLP‑1 Deficiency / GLP‑1 Resistance
Videos
Overview
GLP‑1 deficiency or GLP‑1 resistance is a metabolic condition in which the gut hormone GLP‑1 is either underproduced or unable to signal effectively. GLP‑1 regulates satiety, insulin secretion, blood sugar control, and gastric emptying. When GLP‑1 signaling is impaired, patients experience increased hunger, reduced fullness, cravings, impaired glucose control, and difficulty losing weight. GLP‑1 dysfunction is common in obesity, insulin resistance, and metabolic syndrome.
Causes
Causes include obesity, insulin resistance, chronic inflammation, impaired gut hormone signaling, genetic factors, and metabolic adaptation. Low GLP‑1 production may also occur after certain foregut surgeries or in chronic gastrointestinal disorders.
Risk Factors
Risk factors include obesity, metabolic syndrome, insulin resistance, Type 2 diabetes, chronic inflammation, poor diet quality, and sedentary lifestyle.
How GLP‑1 Dysfunction Affects the Body
GLP‑1 deficiency or resistance increases hunger, reduces satiety, impairs insulin secretion, worsens glucose control, and slows metabolic efficiency. Patients may feel hungry soon after meals and struggle with appetite regulation.
Complications
Complications include weight gain, insulin resistance, prediabetes, Type 2 diabetes, fatty liver disease, and worsening metabolic syndrome.
Symptoms and Signs
Symptoms include increased hunger, reduced fullness, cravings, impaired glucose control, fatigue, and difficulty losing weight.
Diagnosis
Diagnosis includes metabolic evaluation, glucose testing, insulin testing, body composition analysis, and assessment for metabolic syndrome. GLP‑1 levels may be measured in specialized research settings.
Differential Diagnosis
Conditions that mimic GLP‑1 dysfunction include leptin resistance, ghrelin dysregulation, insulin resistance, metabolic adaptation, and thyroid disorders.
Lifestyle Modifications
Lifestyle strategies include increasing protein intake, improving diet quality, resistance training, reducing refined carbohydrates, and improving sleep.
Treatment Options
Treatment includes structured nutrition plans, metabolic therapy, weight-loss interventions, and medical therapy for obesity. Bariatric surgery significantly increases GLP‑1 levels and restores normal satiety signaling.
When to See a Doctor
Seek evaluation if you experience constant hunger, poor satiety, impaired glucose control, or difficulty losing weight.
When to Seek Treatment
Treatment is recommended when GLP‑1 dysfunction contributes to obesity, metabolic syndrome, or impaired glucose regulation.
Long-Term Outlook
Long-term outcomes depend on weight management, metabolic health, and treatment of underlying disorders.
Prognosis
With proper treatment, GLP‑1 signaling improves significantly. Bariatric surgery provides durable restoration of GLP‑1 physiology.
Why Choose Dr. de la Cruz-Muñoz
Dr. Nestor de la Cruz-Muñoz provides advanced metabolic evaluation and treatment for GLP‑1 dysfunction, offering medical and surgical solutions that restore satiety and metabolic balance.
